The global market for siRNA Drug estimated was at US$ 1,596.51 million in the year 2023, is projected to reach a revised size of US$ 12,892.37 million by 2030, growing at a CAGR of 31.94% during the forecast period 2024-2030.
United States market for siRNA Drug was valued at $ 902.04 million in 2023 and will reach $ 5,220.55 million by 2030, at a CAGR of 25.58% during the forecast period of 2024 through 2030.
Europe market for siRNA Drug was valued at $ 505.85 million in 2023 and will reach $ 4,540.73 million by 2030, at a CAGR of 34.51 % during the forecast period of 2024 through 2030.
Rest of World market for siRNA Drug was valued at $ 188.62 million in 2023 and will reach $ 3,131.09 million by 2030, at a CAGR of 44.32 % during the forecast period of 2024 through 2030.
This report aims to provide a comprehensive presentation of the global market for siRNA Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding siRNA Drug.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global siRNA Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
Market Segmentation
This report covers the siRNA Drug segments by company, by Type, by Application, by region and country, and provides market size and CAGR for the history and forecast period (2019-2024, 2025-2030), considering 2023 as the base year. It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
By Company
Alnylam
Novartis
Novo Nordisk
Genzyme
Arrowhead
Silence
Sylentis
Avidity Biosciences
Sirnaomics
Segment by Type
Intravenous Injection
Subcutaneous Injection
Segment by Application
Nervous System Therapy
Endocrine and Metabolic Therapy
Others
By Region
United States
Rest of World
Canada
Japan
Brazil
China
Australia
Europe
Germany
France
U.K.
Italy
Switzerland
Nordic Countries
Rest of Europe
Chapter Outline
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2019-2024, 2025-2030). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Details of FDA-Approved siRNA Drugs
Chapter Five: Detailed analysis of siRNA Drug companies閳� competitive landscape, revenue, market share and ranking, etc.
Chapter Six, Seven and Eight: United States, Europe and rest of world revenue by country.
Chapter Nine: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Ten: Provides siRNA Drug Industry Chain, Key Raw Materials and Upstream Cost Analysis
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: About siRNA Drug Development History and Future Outlook
Chapter Thirteen: Research Finding/Conclusion
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Market Overview of siRNA Drug 1
1.1 siRNA Drug Market Overview 1
1.1.1 siRNA Drug Product Scope 1
1.1.2 siRNA Drug Market Status and Outlook 1
1.2 Global siRNA Drug Market Size Overview by Region 2019 VS 2023 VS 2030 3
1.3 Global siRNA Drug Market Size by Region (2019-2030) 4
1.3.1 Global siRNA Drug Historic Market Size by Region (2019-2024) 4
1.3.2 Global siRNA Drug Market Size Forecast by Region (2025-2030) 5
1.4 Key Regions siRNA Drug Market Size (2019-2030) 7
1.4.1 United States siRNA Drug Market Size (2019-2030) 7
1.4.2 Europe siRNA Drug Market Size (2019-2030) 8
1.4.3 Rest of World siRNA Drug Market Size (2019-2030) 8
2 siRNA Drug Market by Type 9
2.1 Introduction 9
2.1.1 Intravenous Injection 9
2.1.2 Subcutaneous Injection 10
2.2 Global siRNA Drug Market Size by Type: 2019 VS 2023 VS 2030 12
2.2.1 Global siRNA Drug Historic Market Size by Type (2019-2024) 13
2.2.2 Global siRNA Drug Forecasted Market Size by Type (2025-2030) 14
2.3 Key Regions Market Size by Type 14
2.3.1 United States siRNA Drug Revenue Breakdown by Type (2019-2030) 14
2.3.2 Europe siRNA Drug Revenue Breakdown by Type (2019-2030) 15
2.3.3 Rest of World siRNA Drug Revenue Breakdown by Type (2019-2030) 17
3 siRNA Drug Market Overview by Application 19
3.1 Introduction 19
3.1.1 Nervous System Therapy 19
3.1.2 Endocrine and Metabolic Therapy 20
3.1.3 Others 21
3.2 Global siRNA Drug Market Size by Application: 2019 VS 2023 VS 2030 23
3.2.1 Global siRNA Drug Historic Revenue by Application (2019-2024) 24
3.2.2 Global siRNA Drug Forecasted Revenue by Application (2025-2030) 25
3.3 Key Regions Market Size by Application 26
3.3.1 United States siRNA Drug Revenue Breakdown by Application (2019-2030) 26
3.3.2 Europe siRNA Drug Revenue Breakdown by Application (2019-2030) 27
3.3.3 Rest of World siRNA Drug Revenue Breakdown by Application (2019-2030) 28
4 FDA-Approved siRNA Drugs 30
5 siRNA Drug Competition Analysis by Players 31
5.1 Global siRNA Drug Market Size by Players (2019-2024) 31
5.2 Global Top Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in siRNA Drug as of 2023) 32
5.3 Global Key Players of siRNA Drug Head office 32
5.4 Global Key Players of siRNA Drug and Product Research Progress 33
5.5 Global Key Players of siRNA Drug and Establishment Time 33
5.6 siRNA Drug Market Concentration Rate 34
6 United States 36
6.1 United States siRNA Drug Market Size (2019-2030) 36
6.2 United States 36
7 Europe 37
7.1 Europe siRNA Drug Market Size by Country (2019-2030) 37
7.2 Germany 39
7.3 France 39
7.4 U.K. 40
7.5 Italy 40
7.6 Switzerland 41
7.7 Nordic Countries 41
7.8 Rest of Europe 42
8 Rest of World 43
8.1 Rest of World siRNA Drug Market Size by Region (2019-2030) 43
8.2 Canada 45
8.3 Japan 46
8.4 Brazil 47
8.5 China 47
8.6 Australia 48
9 Company (Top Players) Profiles 49
9.1 Alnylam 49
9.1.1 Alnylam Profile 49
9.1.2 Alnylam Main Business 49
9.1.3 Alnylam siRNA Drug Products, Services and Solutions 50
9.1.4 Alnylam siRNA Drug Revenue (US$ Million) & (2019-2024) 51
9.1.5 Alnylam Recent Developments 52
9.2 Novartis 52
9.2.1 Novartis Profile 52
9.2.2 Novartis Main Business 53
9.2.3 Novartis siRNA Drug Products, Services and Solutions 53
9.2.4 Novartis siRNA Drug Revenue (US$ Million) & (2019-2024) 53
9.2.5 Novartis Recent Developments 54
9.3 Novo Nordisk 54
9.3.1 Novo Nordisk Profile 54
9.3.2 Novo Nordisk Main Business 54
9.3.3 Novo Nordisk siRNA Drug Products, Services and Solutions 55
9.3.4 Novo Nordisk siRNA Drug Revenue (US$ Million) & (2019-2024) 55
9.3.5 Novo Nordisk Recent Developments 56
9.4 Genzyme 56
9.4.1 Genzyme Profile 56
9.4.2 Genzyme Main Business 56
9.4.3 Genzyme siRNA Drug Products, Services and Solutions 57
9.4.4 Genzyme Recent Developments 57
9.5 Arrowhead 58
9.5.1 Arrowhead Profile 58
9.5.2 Arrowhead Main Business 58
9.5.3 Arrowhead siRNA Drug Products, Services and Solutions 59
9.5.4 Arrowhead Recent Developments 60
9.6 Silence 60
9.6.1 Silence Profile 60
9.6.2 Silence Main Business 60
9.6.3 Silence siRNA Drug Products, Services and Solutions 61
9.6.4 Silence Recent Developments 62
9.7 Sylentis 63
9.7.1 Sylentis Profile 63
9.7.2 Sylentis Main Business 63
9.7.3 Sylentis siRNA Drug Products, Services and Solutions 64
9.7.4 Sylentis Recent Developments 65
9.8 Avidity Biosciences 65
9.8.1 Avidity Biosciences Profile 65
9.8.2 Avidity Biosciences Main Business 66
9.8.3 Avidity Biosciences siRNA Drug Products, Services and Solutions 66
9.8.4 Avidity Biosciences Recent Developments 67
9.9 Sirnaomics 67
9.9.1 Sirnaomics Profile 67
9.9.2 Sirnaomics Main Business 68
9.9.3 Sirnaomics siRNA Drug Products, Services and Solutions 68
9.9.4 Sirnaomics Recent Developments 69
10 siRNA Drug Industry Chain, Key Raw Materials and Upstream Cost Analysis 70
10.1 siRNA Drug Industrial Chain Analysis 70
10.2 siRNA Drug Key Raw Materials 70
10.3 Upstream Cost Proportion 71
11 siRNA Drug Market Dynamics 72
11.1 siRNA Drug Industry Trends 72
11.2 siRNA Drug Market Drivers 72
11.3 siRNA Drug Market Challenges 73
11.4 siRNA Drug Market Restraints 73
12 siRNA Drug Development History and Future Outlook 74
12.1 Evolution of siRNA Drug 74
12.2 Mechanism of siRNA Drug: Targeted Gene Silencing with High Specificity 75
12.3 Limitations and Improvement Strategies of siRNA Drug 76
13 Research Finding/Conclusion 77
14 Methodology and Data Source 78
14.1 Methodology/Research Approach 78
14.1.1 Research Programs/Design 78
14.1.2 Market Size Estimation 79
14.1.3 Market Breakdown and Data Triangulation 80
14.2 Data Source 81
14.2.1 Secondary Sources 81
14.2.2 Primary Sources 82
14.3 Author List 83
14.4 Disclaimer 84
閳�
Alnylam
Novartis
Novo Nordisk
Genzyme
Arrowhead
Silence
Sylentis
Avidity Biosciences
Sirnaomics
听
听
*If Applicable.